LAV portfolio

LAV (Venture capital) is known to hold 80 companies, 12 of them startups. 4 of them are hiring now, with 1,012 open roles. In the last 12 months rounds in the press named it 1 times (1 as the lead). Its companies closed 2 venture rounds in 12 months, raising $106.5M. Most of them work in Oncology Therapeutics, Cell & Gene Therapy, Drug Discovery.

Source: Alion Venture capital Oct 7, 2026
Investments
80
12 of them startups
Hiring now
4
1,012 open roles
Deals in 12 months
1
1 as the lead
Rounds in 12 months
2
$106.5M raised
Exits
10

Companies LAV has invested in

QuantX Biosciences Series B $85M · 7 mo ago lead round in the pressFeb 8
NextCure, Inc. Venture round $21.5M · 10 mo ago portfolio pageSep 25
Inhibrx United States Venture round $200M · 3 yr ago portfolio pageSep 25
EdiGene Series B $62M · 5 yr ago portfolio pageSep 25
Perfuse Therapeutics United States Venture round $9M · 6 yr ago portfolio pageSep 25
Blackdiamondtherapeutics Venture round $85M · 6 yr ago portfolio pageSep 25
Readcoor Venture round $26.8M · 7 yr ago portfolio pageSep 25
One moment, please... Venture round $100M · 7 yr ago portfolio pageSep 25
Tptherapeutics Venture round $80M · 7 yr ago portfolio pageSep 25
Metacrine Venture round $65M · 8 yr ago portfolio pageSep 25
Glaukos United States Venture round $25M · 8 yr ago portfolio pageSep 25
Nuveramedical Venture round $11.7M · 9 yr ago portfolio pageSep 25
Merck & Co. Prescription Drugs · United States 995 roles portfolio pageSep 25
Legend Biotech Cell & Gene Therapy · United States 41 roles portfolio pageSep 25
Crown Bioscience Clinical Trial Services (CRO) 18 roles portfolio pageSep 25
Agilent EHR & Clinical Software portfolio pageSep 25
Airdoc Medical AI · China portfolio pageSep 25
Co., Ltd. Cell & Gene Therapy portfolio pageSep 25
Connectbiopharma Immunology & Inflammation Therapeutics portfolio pageSep 25
Cullinan Therapeutics Immunology & Inflammation Therapeutics portfolio pageSep 25
Gracell Biotechnologies Inc. Cell & Gene Therapy portfolio pageSep 25
Insilico Drug Discovery AI portfolio pageSep 25
Rona Therapeutics Cardiometabolic Therapeutics portfolio pageSep 25
Sonoma Biotherapeutics Cell & Gene Therapy portfolio pageSep 25
Tempest Therapeutics Oncology Therapeutics portfolio pageSep 25

Open roles at LAV portfolio companies

1,012 open roles at 4 of its companies

Focus

Markets
Oncology Therapeutics6%
Cell & Gene Therapy5%
Drug Discovery4%
Immunology & Inflammation Therapeutics3%
Precision Medicine1%
EHR & Clinical Software1%
Scientific & Lab Software1%
Computer Vision1%
Where its companies are
United States6%
China1%
Stage of its companies
Venture, series not stated83%
Series B17%

Questions about LAV

How many companies has LAV invested in?

LAV is known to hold 80 companies: 12 startups, and 10 exits so far, read from its own portfolio page and the funding rounds that name it.

Is LAV investing now?

Yes: in the last 12 months 1 rounds in the press named LAV (1 as the lead), and 0 companies joined its portfolio page in 90 days.

What does LAV invest in?

The markets of the companies LAV holds: Oncology Therapeutics (6%), Cell & Gene Therapy (5%), Drug Discovery (4%), Immunology & Inflammation Therapeutics (3%), Precision Medicine (1%).

Which LAV portfolio companies are hiring?

4 companies LAV holds are hiring now, with 1,012 open roles listed on this page.

Who does LAV invest alongside?

The investors that hold the most companies together with LAV: Qiming Venture Partners, OrbiMed, RA Capital Management, Nextech Invest, Sofinnova Investments.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 3; 1 rounds in the press that name it

LAV portfolio: 80 known companies. Alion, Oct 7, 2026. https://alion.io/company/lav-3/portfolio

Licence: CC BY-SA 4.0JSON